Semin Respir Crit Care Med 2020; 41(06): 806-816
DOI: 10.1055/s-0040-1710074
Review Article

Comorbidities and Readmissions in Survivors of Acute Hypercapnic Respiratory Failure

Dan Adler
1   Division of Lung Diseases, Geneva University Hospitals, Geneva, Switzerland
2   Faculty of Medicine, University of Geneva Medical School, Geneva, Switzerland
,
Giulia Cavalot
3   Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada
4   Keenan Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Canada
5   Division of Internal Medicine, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy
,
Laurent Brochard
3   Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada
4   Keenan Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Canada
› Author Affiliations

Abstract

Chronic obstructive pulmonary disease (COPD) is defined by chronic airflow obstruction, but is presently considered as a complex, heterogeneous, and multicomponent disease in which comorbidities and extrapulmonary manifestations make important contributions to disease expression. COPD-related hospital readmission. In particular frequent intensive care unit (ICU) readmissions for exacerbations represent a major challenge and place a high burden on patient outcomes and health-related quality of life, as well as on the healthcare system.

In this narrative review, we first address major and often undiagnosed comorbidities associated with COPD that could have an impact on hospital readmission after an index ICU admission for acute hypercapnic respiratory failure. Some guidance for treatment is discussed. Second, we present predictors of hospital and ICU readmission and discuss various strategies to reduce such events.

There is a strong rationale to detect and treat major comorbidities early after index ICU admission for acute hypercapnic respiratory failure. It still remains unclear, however, if a comprehensive and holistic approach to comorbidities in frail patients surviving hypercapnic respiratory failure can efficiently reduce the readmission rate.



Publication History

Article published online:
03 August 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers
333 Seventh Avenue, New York, NY 10001, USA.

 
  • References

  • 1 Gershon AS, Wang C, Wilton AS, Raut R, To T. Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in Ontario, Canada, 1996 to 2007: a population-based study. Arch Intern Med 2010; 170 (06) 560-565
  • 2 Mathers CD, Loncar D. Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLoS Med 2006; 3 (11) 209-224
  • 3 Shah T, Churpek MM, Coca Perraillon M, Konetzka RT. Understanding why patients with COPD get readmitted: a large national study to delineate the Medicare population for the readmissions penalty expansion. Chest 2015; 147 (05) 1219-1226
  • 4 Guerrero M, Crisafulli E, Liapikou A. et al. Readmission for acute exacerbation within 30 days of discharge is associated with a subsequent progressive increase in mortality risk in COPD Patients: a long-term observational study. PLoS One 2016; 11 (03) e0150737
  • 5 Roberts CM, Lowe D, Bucknall CE, Ryland I, Kelly Y, Pearson MG. Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax 2002; 57 (02) 137-141
  • 6 Garcia-Aymerich J, Farrero E, Félez MA, Izquierdo J, Marrades RM, Antó JM. Estudi del Factors de Risc d'Agudització de la MPOC investigators. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003; 58 (02) 100-105
  • 7 Lau AC-W, Yam LY-C, Poon E. Hospital re-admission in patients with acute exacerbation of chronic obstructive pulmonary disease. Respir Med 2001; 95 (11) 876-884
  • 8 Chu CM, Chan VL, Lin AWN, Wong IWY, Leung WS, Lai CKW. Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax 2004; 59 (12) 1020-1025
  • 9 Hartl S, Lopez-Campos JL, Pozo-Rodriguez F. et al. Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit. Eur Respir J 2016; 47 (01) 113-121
  • 10 Ankjærgaard KL, Rasmussen DB, Schwaner SH, Andreassen HF, Hansen EF, Wilcke JT. COPD: Mortality and readmissions in relation to number of admissions with noninvasive ventilation. COPD 2017; 14 (01) 30-36
  • 11 Fazekas AS, Aboulghaith M, Kriz RC. et al. Long-term outcomes after acute hypercapnic COPD exacerbation: first-ever episode of non-invasive ventilation. Wien Klin Wochenschr 2018; 130 (19-20): 561-568
  • 12 Yu T-C, Zhou H, Suh K, Arcona S. Assessing the importance of predictors in unplanned hospital readmissions for chronic obstructive pulmonary disease. Clinicoecon Outcomes Res 2015; 7: 37-51
  • 13 Suissa S, Dell'Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 2012; 67 (11) 957-963
  • 14 Donaldson GC, Wilkinson TMA, Hurst JR, Perera WR, Wedzicha JA. Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171 (05) 446-452
  • 15 Wedzicha JA, Brill SE, Allinson JP, Donaldson GC. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med 2013; 11: 181
  • 16 Dalal AA, Shah M, D'Souza AO, Rane P. Costs of inpatient and emergency department care for chronic obstructive pulmonary disease in an elderly Medicare population. J Med Econ 2010; 13 (04) 591-598
  • 17 Singh D, Agusti A, Anzueto A. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J 2019; 53 (05) 1900164
  • 18 Bourke SC, Piraino T, Pisani L, Brochard L, Elliott MW. Beyond the guidelines for non-invasive ventilation in acute respiratory failure: implications for practice. Lancet Respir Med 2018; 6 (12) 935-947
  • 19 Lindenauer PK, Stefan MS, Shieh MS, Pekow PS, Rothberg MB, Hill NS. Outcomes associated with invasive and noninvasive ventilation among patients hospitalized with exacerbations of chronic obstructive pulmonary disease. JAMA Intern Med 2014; 174 (12) 1982-1993
  • 20 Divo M, Cote C, de Torres JP. et al; BODE Collaborative Group. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186 (02) 155-161
  • 21 Vanfleteren LE, Spruit MA, Groenen M. et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187 (07) 728-735
  • 22 Divo MJ, Celli BR, Poblador-Plou B. et al; EpiChron—BODE Collaborative Group. Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: evidence from the EpiChron cohort. PLoS One 2018; 13 (02) e0193143
  • 23 Divo MJ, Martinez CH, Mannino DM. Ageing and the epidemiology of multimorbidity. Eur Respir J 2014; 44 (04) 1055-1068
  • 24 Vanfleteren LEGW, Spruit MA, Wouters EFM, Franssen FME. Management of chronic obstructive pulmonary disease beyond the lungs. Lancet Respir Med 2016; 4 (11) 911-924
  • 25 Hillas G, Perlikos F, Tsiligianni I, Tzanakis N. Managing comorbidities in COPD. Int J Chron Obstruct Pulmon Dis 2015; 10: 95-109
  • 26 Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J 2006; 28 (06) 1245-1257
  • 27 Vanfleteren LE, Franssen FM, Uszko-Lencer NH. et al. Frequency and relevance of ischemic electrocardiographic findings in patients with chronic obstructive pulmonary disease. Am J Cardiol 2011; 108 (11) 1669-1674
  • 28 Triest FJ, Franssen FM, Spruit MA, Groenen MT, Wouters EF, Vanfleteren LE. Poor agreement between chart-based and objectively identified comorbidities of COPD. Eur Respir J 2015; 46 (05) 1492-1495
  • 29 Watz H, Waschki B, Kirsten A. et al. The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest 2009; 136 (04) 1039-1046
  • 30 Barr RG, Ahmed FS, Carr JJ. et al. Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study. Eur Respir J 2012; 39 (04) 846-854
  • 31 McAllister DA, Maclay JD, Mills NL. et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 176 (12) 1208-1214
  • 32 Clarenbach CF, Sievi NA, Brock M, Schneiter D, Weder W, Kohler M. Lung volume reduction surgery and improvement of endothelial function and blood pressure in patients with chronic obstructive pulmonary disease. A randomized controlled trial. Am J Respir Crit Care Med 2015; 192 (03) 307-314
  • 33 Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32 (04) 962-969
  • 34 McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA. TORCH Clinical Endpoint Committee. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 2007; 62 (05) 411-415
  • 35 Bhatt SP, Dransfield MT. Chronic obstructive pulmonary disease and cardiovascular disease. Transl Res 2013; 162 (04) 237-251
  • 36 Rutten FH, Cramer M-JM, Grobbee DE. et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 2005; 26 (18) 1887-1894
  • 37 Abroug F, Ouanes-Besbes L, Nciri N. et al. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers. Am J Respir Crit Care Med 2006; 174 (09) 990-996
  • 38 Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med 2015; 3 (08) 631-639
  • 39 Høiseth AD, Neukamm A, Karlsson BD, Omland T, Brekke PH, Søyseth V. Elevated high-sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary disease. Thorax 2011; 66 (09) 775-781
  • 40 Terzano C, Romani S, Conti V, Paone G, Oriolo F, Vitarelli A. Atrial fibrillation in the acute, hypercapnic exacerbations of COPD. Eur Rev Med Pharmacol Sci 2014; 18 (19) 2908-2917
  • 41 Dransfield MT, Rowe SM, Johnson JE, Bailey WC, Gerald LB. Use of β blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Thorax 2008; 63 (04) 301-305
  • 42 Rutten FH, Zuithoff NP, Hak E, Grobbee DE, Hoes AW. β-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease. Arch Intern Med 2010; 170 (10) 880-887
  • 43 Nielsen AO, Pedersen L, Sode BF, Dahl M. β-Blocker therapy and risk of chronic obstructive pulmonary disease - a Danish Nationwide Study of 1·3 million individuals. EClinicalMedicine 2019; 7: 21-26
  • 44 Lipworth B, Skinner D, Devereux G. et al. Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease. Heart 2016; 102 (23) 1909-1914
  • 45 Dransfield MT, Voelker H, Bhatt SP. et al; BLOCK COPD Trial Group. Metoprolol for the prevention of acute exacerbations of COPD. N Engl J Med 2019; 381 (24) 2304-2314
  • 46 Lozano R, Naghavi M, Foreman K. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380 (9859): 2095-2128
  • 47 Benjafield AV, Ayas NT, Eastwood PR. et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med 2019; 7 (08) 687-698
  • 48 Shawon MS, Perret JL, Senaratna CV, Lodge C, Hamilton GS, Dharmage SC. Current evidence on prevalence and clinical outcomes of co-morbid obstructive sleep apnea and chronic obstructive pulmonary disease: a systematic review. Sleep Med Rev 2017; 32: 58-68
  • 49 Mokhlesi B, Masa JF, Brozek JL. et al. Evaluation and management of obesity hypoventilation syndrome. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 2019; 200 (03) e6-e24
  • 50 Köhnlein T, Windisch W, Köhler D. et al. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med 2014; 2 (09) 698-705
  • 51 Murphy PB, Rehal S, Arbane G. et al. Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation: a randomized clinical trial. JAMA 2017; 317 (21) 2177-2186
  • 52 Machado MC, Vollmer WM, Togeiro SM. et al. CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD. Eur Respir J 2010; 35 (01) 132-137
  • 53 Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med 2010; 182 (03) 325-331
  • 54 Borel JC, Pepin JL, Pison C. et al. Long-term adherence with non-invasive ventilation improves prognosis in obese COPD patients. Respirology 2014; 19 (06) 857-865
  • 55 Weitzenblum E, Chaouat A, Kessler R, Canuet M. Overlap syndrome: obstructive sleep apnea in patients with chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5 (02) 237-241
  • 56 McNicholas WT. COPD-OSA overlap syndrome: evolving evidence regarding epidemiology, clinical consequences, and management. Chest 2017; 152 (06) 1318-1326
  • 57 Malhotra A, Schwartz AR, Schneider H. et al; ATS Assembly on Sleep and Respiratory Neurobiology. Research priorities in pathophysiology for sleep-disordered breathing in patients with chronic obstructive pulmonary disease. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med 2018; 197 (03) 289-299
  • 58 Randerath W, Bassetti CL, Bonsignore MR. et al. Challenges and perspectives in obstructive sleep apnoea: report by an ad hoc working group of the Sleep Disordered Breathing Group of the European Respiratory Society and the European Sleep Research Society. Eur Respir J 2018; 52 (03) 1702616
  • 59 Adler D, Pépin J-L, Dupuis-Lozeron E. et al. Comorbidities and subgroups of patients surviving severe acute hypercapnic respiratory failure in the intensive care unit. Am J Respir Crit Care Med 2017; 196 (02) 200-207
  • 60 Thille AW, Córdoba-Izquierdo A, Maitre B, Boyer L, Brochard L, Drouot X. High prevalence of sleep apnea syndrome in patients admitted to ICU for acute hypercapnic respiratory failure: a preliminary study. Intensive Care Med 2018; 44 (02) 267-269
  • 61 Adler D, Dupuis-Lozeron E, Janssens JP. et al. Obstructive sleep apnea in patients surviving acute hypercapnic respiratory failure is best predicted by static hyperinflation. PLoS One 2018; 13 (10) e0205669
  • 62 Hanania NA, Müllerova H, Locantore NW. et al; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study investigators. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med 2011; 183 (05) 604-611
  • 63 Coventry PA, Hind D. Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: systematic review and meta-analysis. J Psychosom Res 2007; 63 (05) 551-565
  • 64 Dodd JW. Lung disease as a determinant of cognitive decline and dementia. Alzheimers Res Ther 2015; 7 (01) 32
  • 65 Torres-Sánchez I, Rodríguez-Alzueta E, Cabrera-Martos I, López-Torres I, Moreno-Ramírez MP, Valenza MC. Cognitive impairment in COPD: a systematic review. J Bras Pneumol 2015; 41 (02) 182-190
  • 66 Hung WW, Wisnivesky JP, Siu AL, Ross JS. Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180 (02) 134-137
  • 67 Almagro P, Barreiro B, Ochoa de Echaguen A. et al. Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease. Respiration 2006; 73 (03) 311-317
  • 68 Soler-Cataluña JJ, Martínez-García MA, Sánchez LS, Tordera MP, Sánchez PR. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients. Respir Med 2009; 103 (05) 692-699
  • 69 Almagro P, Soriano JB, Cabrera FJ. et al; Working Group on COPD, SpanishSociety of Internal Medicine*. Short- and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index. Chest 2014; 145 (05) 972-980
  • 70 Echevarria C, Steer J, Heslop-Marshall K. et al. The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD. Thorax 2017; 72 (08) 686-693
  • 71 Niewoehner DE, Lokhnygina Y, Rice K. et al. Risk indexes for exacerbations and hospitalizations due to COPD. Chest 2007; 131 (01) 20-28
  • 72 Gudmundsson G, Gislason T, Janson C. et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J 2005; 26 (03) 414-419
  • 73 Celli BR, Cote CG, Marin JM. et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350 (10) 1005-1012
  • 74 Spece LJ, Epler EM, Donovan LM. et al. Role of comorbidities in treatment and outcomes after chronic obstructive pulmonary disease exacerbations. Ann Am Thorac Soc 2018; 15 (09) 1033-1038
  • 75 Sharif R, Parekh TM, Pierson KS, Kuo Y-F, Sharma G. Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease. Ann Am Thorac Soc 2014; 11 (05) 685-694
  • 76 Miravitlles M, Guerrero T, Mayordomo C, Sánchez-Agudo L, Nicolau F, Segú JL. The EOLO Study Group. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. Respiration 2000; 67 (05) 495-501
  • 77 Singh G, Zhang W, Kuo Y-F, Sharma G. Association of psychological disorders with 30-day readmission rates in patients with COPD. Chest 2016; 149 (04) 905-915
  • 78 Bernabeu-Mora R, García-Guillamón G, Valera-Novella E, Giménez-Giménez LM, Escolar-Reina P, Medina-Mirapeix F. Frailty is a predictive factor of readmission within 90 days of hospitalization for acute exacerbations of chronic obstructive pulmonary disease: a longitudinal study. Ther Adv Respir Dis 2017; 11 (10) 383-392
  • 79 Rothnie KJ, Müllerová H, Smeeth L, Quint JK. Natural history of COPD exacerbations in a general practice based COPD population. Am J Respir Crit Care Med 2018; 198 (04) 464-471
  • 80 Cao Z, Ong KC, Eng P, Tan WC, Ng TP. Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology 2006; 11 (02) 188-195
  • 81 Garcia-Aymerich J, Monsó E, Marrades RM. et al; EFRAM Investigators. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. Am J Respir Crit Care Med 2001; 164 (06) 1002-1007
  • 82 Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159 (01) 158-164
  • 83 Wang Q, Bourbeau J. Outcomes and health-related quality of life following hospitalization for an acute exacerbation of COPD. Respirology 2005; 10 (03) 334-340
  • 84 Hurst JR, Vestbo J, Anzueto A. et al; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363 (12) 1128-1138
  • 85 Adler D, Dupuis-Lozeron E, Richard JC, Janssens JP, Brochard L. Does inspiratory muscle dysfunction predict readmission after intensive care unit discharge?. Am J Respir Crit Care Med 2014; 190 (03) 347-350
  • 86 Vega Reyes JA, Montero Pérez-Barquero M, Sánchez Guijo P. [Assessing COPD-associated morbidity: factors of prognosis]. Med Clin (Barc) 2004; 122 (08) 293-297
  • 87 Dupuis-Lozeron E, Soccal PM, Janssens J-P, Similowski T, Adler D. Severe dyspnea is an independent predictor of readmission or death in COPD patients surviving acute hypercapnic respiratory failure in the ICU. Front Med (Lausanne) 2018; 5: 163
  • 88 Wilkinson TMA, Donaldson GC, Hurst JR, Seemungal TAR, Wedzicha JA. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 169 (12) 1298-1303
  • 89 Kiser TH, Allen RR, Valuck RJ, Moss M, Vandivier RW. Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2014; 189 (09) 1052-1064
  • 90 Abroug F, Ouanes-Besbes L, Fkih-Hassen M. et al. Prednisone in COPD exacerbation requiring ventilatory support: an open-label randomised evaluation. Eur Respir J 2014; 43 (03) 717-724
  • 91 Gavish R, Levy A, Dekel OK, Karp E, Maimon N. The association between hospital readmission and pulmonologist follow-up visits in patients with COPD. Chest 2015; 148 (02) 375-381
  • 92 Albitar HAH, Iyer VN. Adherence to global initiative for chronic obstructive lung disease guidelines in the real world: current understanding, barriers, and solutions. Curr Opin Pulm Med 2019
  • 93 Gershon A, Mecredy G, Croxford R, To T, Stanbrook MB, Aaron SD. Canadian Respiratory Research Network. Outcomes of patients with chronic obstructive pulmonary disease diagnosed with or without pulmonary function testing. CMAJ 2017; 189 (14) E530-E538
  • 94 Bahadori K, FitzGerald JM, Levy RD, Fera T, Swiston J. Risk factors and outcomes associated with chronic obstructive pulmonary disease exacerbations requiring hospitalization. Can Respir J 2009; 16 (04) e43-e49
  • 95 McGhan R, Radcliff T, Fish R, Sutherland ER, Welsh C, Make B. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 2007; 132 (06) 1748-1755
  • 96 Roberts MH, Clerisme-Beaty E, Kozma CM, Paris A, Slaton T, Mapel DW. A retrospective analysis to identify predictors of COPD-related rehospitalization. BMC Pulm Med 2016; 16 (01) 68
  • 97 Vestbo J, Anderson W, Coxson HO. et al; ECLIPSE investigators. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 2008; 31 (04) 869-873
  • 98 Müllerova H, Maselli DJ, Locantore N. et al. Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. Chest 2015; 147 (04) 999-1007
  • 99 Prieto-Centurion V, Markos MA, Ramey NI. et al. Interventions to reduce rehospitalizations after chronic obstructive pulmonary disease exacerbations. A systematic review. Ann Am Thorac Soc 2014; 11 (03) 417-424
  • 100 Casas A, Troosters T, Garcia-Aymerich J. et al; members of the CHRONIC Project. Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J 2006; 28 (01) 123-130
  • 101 Kwok T, Lum CM, Chan HS, Ma HM, Lee D, Woo J. A randomized, controlled trial of an intensive community nurse-supported discharge program in preventing hospital readmissions of older patients with chronic lung disease. J Am Geriatr Soc 2004; 52 (08) 1240-1246
  • 102 Linden A, Butterworth S. A comprehensive hospital-based intervention to reduce readmissions for chronically ill patients: a randomized controlled trial. Am J Manag Care 2014; 20 (10) 783-792
  • 103 Seys D, Bruyneel L, Sermeus W. et al. Teamwork and adherence to recommendations explain the effect of a care pathway on reduced 30-day readmission for patients with a COPD exacerbation. COPD 2018; 15 (02) 157-164
  • 104 Ospina MB, Mrklas K, Deuchar L. et al. A systematic review of the effectiveness of discharge care bundles for patients with COPD. Thorax 2017; 72 (01) 31-39
  • 105 Yang F, Xiong Z-F, Yang C. et al. Continuity of care to prevent readmissions for patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. COPD 2017; 14 (02) 251-261
  • 106 Aboumatar H, Naqibuddin M, Chung S. et al. Effect of a hospital-initiated program combining transitional care and long-term self-management support on outcomes of patients hospitalized with chronic obstructive pulmonary disease: a randomized clinical trial. JAMA 2019; 322 (14) 1371-1380
  • 107 Sharma G, Kuo Y-F, Freeman JL, Zhang DD, Goodwin JS. Outpatient follow-up visit and 30-day emergency department visit and readmission in patients hospitalized for chronic obstructive pulmonary disease. Arch Intern Med 2010; 170 (18) 1664-1670
  • 108 Sorknaes AD, Madsen H, Hallas J, Jest P, Hansen-Nord M. Nurse tele-consultations with discharged COPD patients reduce early readmissions--an interventional study. Clin Respir J 2011; 5 (01) 26-34
  • 109 Pedersen PU, Ersgard KB, Soerensen TB, Larsen P. Effectiveness of structured planned post discharge support to patients with chronic obstructive pulmonary disease for reducing readmission rates: a systematic review. JBI Database Syst Rev Implement Reports 2017; 15 (08) 2060-2086
  • 110 Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; (04) CD003793
  • 111 Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011; (10) CD005305
  • 112 Puhan MA, Gimeno-Santos E, Cates CJ, Troosters T. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2016; 12: CD005305
  • 113 Brochard L, Mancebo J, Wysocki M. et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995; 333 (13) 817-822
  • 114 Kramer N, Meyer TJ, Meharg J, Cece RD, Hill NS. Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med 1995; 151 (06) 1799-1806
  • 115 Rochwerg B, Brochard L, Elliott MW. et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 2017; 50 (02) 1602426
  • 116 Casanova C, Celli BR, Tost L. et al. Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD. Chest 2000; 118 (06) 1582-1590
  • 117 Clini E, Sturani C, Rossi A. et al; Rehabilitation and Chronic Care Study Group, Italian Association of Hospital Pulmonologists (AIPO). The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J 2002; 20 (03) 529-538
  • 118 Struik FM, Sprooten RTM, Kerstjens HAM. et al. Nocturnal non-invasive ventilation in COPD patients with prolonged hypercapnia after ventilatory support for acute respiratory failure: a randomised, controlled, parallel-group study. Thorax 2014; 69 (09) 826-834
  • 119 Dreher M, Storre JH, Schmoor C, Windisch W. High-intensity versus low-intensity non-invasive ventilation in patients with stable hypercapnic COPD: a randomised crossover trial. Thorax 2010; 65 (04) 303-308
  • 120 Schwarz SB, Magnet FS, Windisch W. Why high-intensity NPPV is favourable to low-intensity NPPV: clinical and physiological reasons. COPD 2017; 14 (04) 389-395
  • 121 Storre JH, Matrosovich E, Ekkernkamp E. et al. Home mechanical ventilation for COPD: high-intensity versus target volume noninvasive ventilation. Respir Care 2014; 59 (09) 1389-1397
  • 122 Ergan B, Oczkowski S, Rochwerg B. et al. European Respiratory Society guidelines on long-term home non-invasive ventilation for management of COPD. Eur Respir J 2019; 54 (03) pii:1901003